Pharma Integrates 2022 Track 3

ENABLERS

How do we enable a better Industry, through creating diverse skilled teams, empowering the patient and navigating the economic and regulatory environment 

Welcome and opening remarks

Susan Rienow, Country President UK, Pfizer & Vice President ABPI

Fireside Chat

TIM FERRIS | National Director of Transformation | NHS England and NHS Improvement

Interviewed by

JENNY OUSBEY | Chief Executive Officer & Founder | Ovid Health

Fireside Chat

LORD DAVID PRIOR | Deputy Chairman UK and Global Senior Advisor | Lazard

Interviewed by

TAMSIN BERRY | Head of Policy and Partnerships, AreteiaTx | Partner, Population Health Partners

Patients in charge

How should we engage and empower patients in their healthcare journeys?

FACILITATED BY

Jenny Ousbey | Chief Executive Officer & Founder | Ovid Health

PANELLISTS

Peter Bannister | Honorary Chair | University of Birmingham Centre for Regulatory Science and Innovation
Tim Ringrose | Chief Executive Officer | Cognitant
Nigel Brokenshire | Head of Digital Healthcare UK/I | Bayer PLC
Helen Quinn | Clinical Director | NIHR PRC: Exeter

Vive la difference

What is the evidence that we need to have more diverse and inclusive organisations?
How do we harness the diversity we know brings better business results?
What are the challenges in bringing diverse individuals together and how do we overcome them?

FACILITATED BY

Kathryn Simpson | Business Consultant | Kathryn Simpson Consulting Limited

PANELLISTS

Michael George | Vice President, Global Head MedSci & iiGM Global Therapeutic Area Head | Labcorp Clinical Development Limited
Amina Udechuku | Head of Vaccines, UK | Takeda UK
Sally Moore | Director and Chartered Psychologist | Top Stream Coaching and Consulting
Melissa Hanna-Brown | Senior Director, Global External Strategic Innovation Lead | Pfizer

Are you in or out sourcing?

What is the strategic role of the CDMO and CRO? How has partnering changed?

FACILITATED BY

James Fry | Partner and Head of Life Sciences, | Mills & Reeve

PANELLISTS

Catherine Blackman | Vice President for Therapy Supply Chain | GSK
Jason Cameron | Chief Operating Officer | Orphan Drug Consulting
Steve Barr | Vice President Business Development, | SK biotek
Steven Facer | Vice President of Business Development EU/ROW | Adare Pharma Solutions
James Crooks | EU Regulatory Affairs Director | ProductLife Group

Trials and tribulations

What are the latest innovations in clinical trials? How are this being adopted?

FACILITATED BY

Stuart Redding | Chief Executive Officer | MRN

PANELLISTS

Michael Young | Co-founder | Lindus Health
Christopher Morton | Chief Executive Officer | ELEM Biotech
James Chennells | Head Clinical Trial Technology Strategy | Bayer
Helen Shaw | Co-Founder and Managing Director | The VCTC
Matthew McLoughlin | CEO and Founder | Synetic